Compulsive policy on drug prices hampers the pharmaceutical industry

Published: 2002-04-11 06:59:00

Updated: 2002-04-11 06:59:00

In its recent executives' meeting, the Korean Pharmaceutical Manufacturers Association (KPMA) has demanded that the government should promote to foster better management atmosphere of the domestic pharmaceutical industry towards R&D new drug projects, instead of waivering excessive control on the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK